Glioblstoma WHO grade IV research hub

A multicenter randomized double-blinded controlled phase 2 study evaluating the efficacy of valganciclovir as add-on therapy in glioblastoma patients

This study looks at whether adding a drug called valganciclovir to standard treatment can help people with a type of brain tumour called glioblastoma live longer. Doctors are comparing it to a dummy pill to see if it makes a difference.